Vaxart Inc (NASDAQ:VXRT)

4.14
Delayed Data
As of Aug 12
 +0.07 / +1.72%
Today’s Change
2.49
Today|||52-Week Range
9.52
-33.97%
Year-to-Date
VAXART, INC. (VXRT) Reports Q2 Loss, Lags Revenue Estimates
Aug 08 / Zacks.com - Paid Partner Content
Could This Unknown Stock Beat Moderna in 2023?
Aug 03 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close4.07
Today’s open4.10
Day’s range4.01 - 4.16
Volume127,981
Average volume (3 months)2,702,849
Market cap$523.1M
Data as of 3:59pm ET, 08/12/2022

Growth & Valuation

Earnings growth (last year)-59.00%
Earnings growth (this year)-39.66%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-77.95%
P/E ratioNM
Price/Sales853.72
Price/Book2.76

Competitors

 Today’s
change
Today’s
% change
BLUEbluebird bio Inc+0.40+6.34%
HRTXHeron Therapeutics I...+0.43+8.83%
MGTXMeiraGTx Holdings PL...+0.71+6.77%
ATRAAtara Biotherapeutic...+1.19+25.70%
Data as of 4:00pm ET, 08/12/2022

Financials

Next reporting dateNovember 16, 2022
EPS forecast (this quarter)-$0.24
Annual revenue (last year)$892.0K
Annual profit (last year)-$70.5M
Net profit margin-7,900.22%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
South San Francisco, California

Forecasts